Literature DB >> 23857303

Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica.

Marcelo Matiello1, Janet Schaefer-Klein, David Sun, Brian G Weinshenker.   

Abstract

IMPORTANCE: To understand the predilection for optic nerve and spinal cord pathologic changes in neuromyelitis optica (NMO). OBJECTIVE TO evaluate tissue-specific expression (RNA and protein) and supramolecular aggregation of aquaporin 4 (AQP4) in mouse, rat, and human tissues.
DESIGN: Quantitative polymerase chain reaction, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and blue native polyacrylamide gel electrophoresis.
SETTING: Laboratory analysis of mouse, rat, and human tissue. PARTICIPANTS: Tissues from control individuals and 1 patient with NMO obtained at autopsy. EXPOSURE: Neuromyelitis optica in the patient. MAIN OUTCOMES AND MEASURES: Tissue-specific messenger RNA and protein expression and supramolecular aggregation of AQP4.
RESULTS: The AQP4 messenger RNA and proteins were much more highly expressed in the optic nerve and spinal cord relative to other regions of the brain and to non-central nervous system tissues in all species evaluated. Large supramolecular aggregates of AQP4 were overrepresented in the optic nerve and spinal cord relative to other central nervous system tissue. There was no difference in AQP4 expression between an individual with NMO and the control samples. CONCLUSIONS AND RELEVANCE: Optic nerve tissue from an individual with NMO did not differ in AQP4 expression from control samples. The relatively high levels of expression and of supramolecular aggregation in the optic nerve and spinal cord may contribute to the predilection of these structures to NMO pathologic changes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23857303     DOI: 10.1001/jamaneurol.2013.3124

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  23 in total

1.  Normal-Appearing Cerebellar Damage in Neuromyelitis Optica Spectrum Disorder.

Authors:  J Sun; N Zhang; Q Wang; X Zhang; W Qin; L Yang; F-D Shi; C Yu
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-20       Impact factor: 3.825

2.  Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodies.

Authors:  Francesco Pisani; Maria Grazia Mola; Laura Simone; Stefania Rosito; Domenico Alberga; Giuseppe Felice Mangiatordi; Gianluca Lattanzi; Orazio Nicolotti; Antonio Frigeri; Maria Svelto; Grazia Paola Nicchia
Journal:  J Biol Chem       Date:  2014-09-19       Impact factor: 5.157

Review 3.  Magnetic resonance imaging in immune-mediated myelopathies.

Authors:  M J Wendebourg; S Nagy; T Derfuss; K Parmar; R Schlaeger
Journal:  J Neurol       Date:  2019-01-29       Impact factor: 4.849

Review 4.  Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis.

Authors:  Hao Meng; Jun Xu; Chenling Pan; Jiaxing Cheng; Yue Hu; Yin Hong; Yuehai Shen; Hua Dai
Journal:  J Neurol       Date:  2016-12-01       Impact factor: 4.849

5.  High risk of postpartum relapses in neuromyelitis optica spectrum disorder.

Authors:  Eric C Klawiter; Riley Bove; Liene Elsone; Enrique Alvarez; Nadja Borisow; Melissa Cortez; Farrah Mateen; Maureen A Mealy; Jaime Sorum; Kerry Mutch; Sean M Tobyne; Klemens Ruprecht; Guy Buckle; Michael Levy; Dean Wingerchuk; Friedemann Paul; Anne H Cross; Anu Jacobs; Tanuja Chitnis; Brian Weinshenker
Journal:  Neurology       Date:  2017-11-01       Impact factor: 9.910

6.  Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.

Authors:  John Soltys; Yiting Liu; Alanna Ritchie; Scott Wemlinger; Kristin Schaller; Hannah Schumann; Gregory P Owens; Jeffrey L Bennett
Journal:  J Clin Invest       Date:  2019-04-08       Impact factor: 14.808

Review 7.  Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.

Authors:  Jeffrey L Bennett; Gregory P Owens
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

Review 8.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 9.  Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Authors:  J L Bennett; J de Seze; M Lana-Peixoto; J Palace; A Waldman; S Schippling; S Tenembaum; B Banwell; B Greenberg; M Levy; K Fujihara; K H Chan; H J Kim; N Asgari; D K Sato; A Saiz; J Wuerfel; H Zimmermann; A Green; P Villoslada; F Paul
Journal:  Mult Scler       Date:  2015-02-06       Impact factor: 6.312

Review 10.  Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Joseph A Lopez; Martina Denkova; Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Clin Transl Immunology       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.